Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Singapore Med J ; 58(5): 246-252, 2017 05.
Artículo en Inglés | MEDLINE | ID: mdl-27121922

RESUMEN

INTRODUCTION: This study aimed to explore the level of knowledge of Muslim patients with diabetes mellitus (DM) regarding DM and the self-management of DM when fasting during Ramadan. METHODS: Muslim patients with DM attending the Diabetes Centre of Singapore General Hospital, Singapore, were surveyed on their knowledge of DM and self-management of DM when fasting during Ramadan. Data on patient demographics, DM history and management of DM during the previous Ramadan was also collected. RESULTS: A total of 92 patients (34 male, 58 female) were surveyed. The mean age of the patients was 53.4 ± 13.3 years. The patients were either Malay (91.3%) or Indian (8.7%), and most (66.3%) had at least a secondary school education. Most (89.1%) had Type 2 DM. The mean duration of DM was 8.7 ± 5.1 years and mean pre-Ramadan haemoglobin A1c was 8.4% ± 1.8%. DM treatment consisted of insulin therapy (37.0%), oral glucose-lowering drugs (35.9%) and combined therapy (22.8%). The mean DM knowledge score was 58.8% for general knowledge and 75.9% for fasting knowledge. During the previous Ramadan, although 71.4% of the patients consulted their physicians, 37.3% did not monitor their blood glucose levels and 47.0% had hypoglycaemic episodes. Among those who had hypoglycaemia, 10.8% continued to fast. CONCLUSION: Unsafe self-management practices were observed among DM patients who fasted during Ramadan. Efforts should be made to bridge the gap between knowledge of DM and self-management of DM.


Asunto(s)
Diabetes Mellitus Tipo 1/psicología , Diabetes Mellitus Tipo 2/psicología , Ayuno/psicología , Conocimientos, Actitudes y Práctica en Salud , Islamismo/psicología , Adulto , Anciano , Anciano de 80 o más Años , Glucemia , Estudios Transversales , Complicaciones de la Diabetes , Diabetes Mellitus Tipo 1/sangre , Diabetes Mellitus Tipo 1/tratamiento farmacológico , Diabetes Mellitus Tipo 1/epidemiología , Diabetes Mellitus Tipo 2/sangre , Diabetes Mellitus Tipo 2/tratamiento farmacológico , Diabetes Mellitus Tipo 2/epidemiología , Femenino , Hospitales Generales , Humanos , Hipoglucemia/complicaciones , Insulina/uso terapéutico , Masculino , Persona de Mediana Edad , Automanejo , Singapur/epidemiología , Encuestas y Cuestionarios , Adulto Joven
2.
Singapore Med J ; 54(7): e133-6, 2013 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-23900475

RESUMEN

A 24-year-old Chinese woman with Graves' disease presented with myositis two months after treatment with carbimazole. The patient's myositis resolved with hydration and cessation of carbimazole. No other causes of myositis were found, and a change in the medication to propylthiouracil was uneventful. Review of the literature suggests a possible genetic susceptibility, as the majority of reported cases are Asian in origin, similar to patients who present with thyroid periodic paralysis. Changing the antithyroid drugs (ATDs) administered, decreasing the dose of pre-existing ATDs in the treatment regimen or addition of levothyroxine has been shown to result in clinical improvement of this complication. These observations suggest various mechanisms of carbimazole-induced myositis in the treatment of Graves' disease, including the direct effect of ATDs on myocytes, immune-related responses secondary to ATDs and rapid decrements in thyroid hormone with ensuing myositis.


Asunto(s)
Antitiroideos/efectos adversos , Carbimazol/efectos adversos , Enfermedad de Graves/tratamiento farmacológico , Miositis/inducido químicamente , Miositis/genética , Femenino , Predisposición Genética a la Enfermedad , Humanos , Miositis/terapia , Adulto Joven
3.
Intern Med ; 51(6): 613-8, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-22449670

RESUMEN

Head and neck paragangliomas that are exclusively or predominantly dopamine-secreting are rare. Surgery and/or radiotherapy are modalities for locoregional tumoral control. Little is known about the efficacy of radiotherapy for biochemical control in such tumors. We report a 62-year-old Chinese man with bilateral carotid body tumors which were exclusively dopamine secreting. The left-sided tumor invaded the skull base and encased the left carotid artery. Surgery was not performed due to high risk of morbidity and mortality. The patient received external beam radiotherapy to bilateral neck regions. Progressive decline and eventual normalization of urinary dopamine excretion was seen together with a slight reduction in tumor size. This is the first report demonstrating the efficacy of radiotherapy for both biochemical and locoregional control of functioning carotid body paragangliomas.


Asunto(s)
Tumor del Cuerpo Carotídeo/metabolismo , Dopamina/metabolismo , Neoplasias Primarias Múltiples/metabolismo , 3-Yodobencilguanidina , Tumor del Cuerpo Carotídeo/diagnóstico , Tumor del Cuerpo Carotídeo/diagnóstico por imagen , Tumor del Cuerpo Carotídeo/radioterapia , Manejo de la Enfermedad , Dopamina/orina , Humanos , Radioisótopos de Yodo , Angiografía por Resonancia Magnética , Masculino , Persona de Mediana Edad , Neoplasias Primarias Múltiples/diagnóstico , Neoplasias Primarias Múltiples/diagnóstico por imagen , Neoplasias Primarias Múltiples/radioterapia , Cintigrafía , Radiofármacos , Inducción de Remisión , Tomografía Computarizada por Rayos X
4.
Endocr Pract ; 16(5): 838-41, 2010.
Artículo en Inglés | MEDLINE | ID: mdl-20570814

RESUMEN

OBJECTIVE: To describe a man with a functioning insulinoma and normal results from two 72-hour fasts who developed hypoglycemia secondary to exaggerated insulin response following glucagon stimulation. METHODS: We report the patient's clinical findings, laboratory findings, and clinical course. We also review the literature for previously reported cases and possible mechanisms. RESULTS: A 49-year-old man presented with hypoglycemic symptoms initially occurring after jogging and well-documented symptomatic hypoglycemia occurring during an evening meal. A 72-hour fast was associated with a serum glucose concentration of 50 mg/dL, suppressed insulin and C-peptide levels, and mildly elevated ß-hydroxybutyrate. Another documented episode of hypoglycemia occurring 3 hours postprandially was associated with elevated insulin and C-peptide and suppressed ß-hydroxybutyrate. A second 72-hour fast provoked asymptomatic hypoglycemia (glucose concentration at 60 hours: 32 mg/dL) with suppressed insulin and measurable ß-hydroxybutyrate. After 72 hours of fasting, glucagon administration led to a decrease in glucose from 50 to 18 mg/dL, elevations in insulin and C-peptide, and suppression of ß-hydroxybutyrate. Computed tomography revealed a mass lesion in the pancreatic tail. Distal pancreatectomy was performed, and the resected specimen demonstrated immunostaining for insulin. Hypoglycemic symptoms resolved postoperatively. CONCLUSIONS: Normal results from a prolonged fast do not preclude an insulinoma and may demonstrate exaggerated insulin secretion from the insulinoma following glucagon administration. In addition to examining the glucose response to glucagon as a surrogate for insulinoma diagnosis, measurement of serum insulin levels following glucagon administration may provide a further clue to the diagnosis of insulinoma.


Asunto(s)
Glucagón/farmacología , Hipoglucemia/inducido químicamente , Hipoglucemia/metabolismo , Insulinoma/diagnóstico , Neoplasias Pancreáticas/diagnóstico , Técnicas de Diagnóstico Endocrino , Ayuno/sangre , Ayuno/metabolismo , Humanos , Hipoglucemia/sangre , Insulinoma/metabolismo , Masculino , Persona de Mediana Edad , Neoplasias Pancreáticas/metabolismo , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...